New hope for elderly myeloma patients: talquetamab trial opens
Disease control
Recruiting now
This study tests a drug called talquetamab in elderly patients whose multiple myeloma has come back after earlier treatments. The drug is given as a shot under the skin and aims to help the body's immune cells attack the cancer. If the drug stops working, another drug called dara…
Phase: PHASE2 • Sponsor: Larysa Sanchez • Aim: Disease control
Last updated May 17, 2026 06:17 UTC